|
US3766774A
(en)
|
1972-02-18 |
1973-10-23 |
H Clark |
Apparatus and method for measuring blood characteristics
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4446122A
(en)
|
1979-12-28 |
1984-05-01 |
Research Corporation |
Purified human prostate antigen
|
|
USRE33405E
(en)
|
1979-12-28 |
1990-10-23 |
Research Corporation Technologies, Inc. |
Purified human prostate antigen
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US4970299A
(en)
|
1986-07-03 |
1990-11-13 |
Sloan-Kettering Institute For Cancer Research |
Monoclonal antibodies selective for prostate cancer
|
|
US5811128A
(en)
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
FR2608988B1
(fr)
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4902615A
(en)
|
1987-03-27 |
1990-02-20 |
Biosciences Corporation Of Texas |
Detection of human cancer cells with antibodies to human cancer nucleolar antigen p120
|
|
DE3812289C2
(de)
|
1987-04-20 |
1995-06-08 |
Mitsubishi Electric Corp |
Leerlaufdrehzahlregelvorrichtung für eine Brennkraftmaschine
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
US5162504A
(en)
|
1988-06-03 |
1992-11-10 |
Cytogen Corporation |
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
|
|
JPH0249596A
(ja)
|
1988-08-09 |
1990-02-19 |
Masamichi Ueda |
ヒト前立腺上皮細胞の表面に特異的に反応するモノクローナル抗体
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5334497A
(en)
|
1988-12-13 |
1994-08-02 |
Hideki Inaba |
Method of feeding a substrate into tubular bioreactor
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US6005087A
(en)
|
1995-06-06 |
1999-12-21 |
Isis Pharmaceuticals, Inc. |
2'-modified oligonucleotides
|
|
US6399754B1
(en)
|
1991-12-24 |
2002-06-04 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides
|
|
US5660985A
(en)
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
|
US5763177A
(en)
|
1990-06-11 |
1998-06-09 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
EP0786469B1
(en)
|
1990-06-11 |
2006-03-01 |
Gilead Sciences, Inc. |
Methods of use of nucleic acid ligands
|
|
US6280932B1
(en)
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
|
US5567588A
(en)
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
|
US5874218A
(en)
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Method for detecting a target compound in a substance using a nucleic acid ligand
|
|
US6716580B2
(en)
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
|
US6001577A
(en)
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
|
US5789163A
(en)
|
1990-06-11 |
1998-08-04 |
Nexstar Pharmaceuticals, Inc. |
Enzyme linked oligonucleotide assays (ELONAS)
|
|
US5853984A
(en)
|
1990-06-11 |
1998-12-29 |
Nexstar Pharmaceuticals, Inc. |
Use of nucleic acid ligands in flow cytometry
|
|
US6699474B1
(en)
|
1990-08-20 |
2004-03-02 |
Erich Hugo Cerny |
Vaccine and immunserum against drugs of abuse
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5175296A
(en)
|
1991-03-01 |
1992-12-29 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-c]quinolin-4-amines and processes for their preparation
|
|
IT1250421B
(it)
|
1991-05-30 |
1995-04-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
|
|
US5766635A
(en)
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US6608201B2
(en)
|
1992-08-28 |
2003-08-19 |
3M Innovative Properties Company |
Process for preparing 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
EP0678034B1
(en)
|
1993-01-11 |
1999-05-26 |
Dana Farber Cancer Institute |
Inducing cytotoxic t lymphocyte responses
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5820879A
(en)
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
DE59403734D1
(de)
|
1993-03-17 |
1997-09-18 |
Silica Gel Gmbh |
Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben
|
|
US5342781A
(en)
|
1993-07-15 |
1994-08-30 |
Su Wei Wen W |
External-loop perfusion air-lift bioreactor
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US6458539B1
(en)
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5500161A
(en)
|
1993-09-21 |
1996-03-19 |
Massachusetts Institute Of Technology And Virus Research Institute |
Method for making hydrophobic polymeric microparticles
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5786204A
(en)
|
1995-01-20 |
1998-07-28 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
|
US5876727A
(en)
|
1995-03-31 |
1999-03-02 |
Immulogic Pharmaceutical Corporation |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US20020150578A1
(en)
|
1995-06-05 |
2002-10-17 |
Human Genome Sciences, Inc. |
Human prostatic specific reductase
|
|
US5843732A
(en)
|
1995-06-06 |
1998-12-01 |
Nexstar Pharmaceuticals, Inc. |
Method and apparatus for determining consensus secondary structures for nucleic acid sequences
|
|
WO1997004747A1
(en)
|
1995-07-27 |
1997-02-13 |
Dunn James M |
Drug delivery systems for macromolecular drugs
|
|
US6096344A
(en)
|
1995-07-28 |
2000-08-01 |
Advanced Polymer Systems, Inc. |
Bioerodible porous compositions
|
|
US6395770B1
(en)
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
|
US5898031A
(en)
|
1996-06-06 |
1999-04-27 |
Isis Pharmaceuticals, Inc. |
Oligoribonucleotides for cleaving RNA
|
|
US20020106647A1
(en)
|
1996-07-24 |
2002-08-08 |
Segal Andrew H. |
Nucleic acid compositions and methods of introducing nucleic acids into cells
|
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
|
JP2001504448A
(ja)
|
1996-08-30 |
2001-04-03 |
フュルステ，イェンス，ペーター |
核酸の鏡面対称選択および進化
|
|
EP1006798A4
(en)
|
1996-09-05 |
2003-03-05 |
Massachusetts Inst Technology |
COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES
|
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
|
US6120666A
(en)
|
1996-09-26 |
2000-09-19 |
Ut-Battelle, Llc |
Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same
|
|
KR100518903B1
(ko)
|
1996-10-25 |
2005-10-06 |
미네소타 마이닝 앤드 매뉴팩춰링 캄파니 |
Ｔｈ2 매개 질병 및 관련 질병의 치료용 면역 반응 조절 화합물
|
|
US7518013B2
(en)
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
|
US7205437B2
(en)
|
1996-11-27 |
2007-04-17 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
|
US6995284B2
(en)
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US7759520B2
(en)
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
|
US6127533A
(en)
|
1997-02-14 |
2000-10-03 |
Isis Pharmaceuticals, Inc. |
2'-O-aminooxy-modified oligonucleotides
|
|
WO1998051325A2
(en)
|
1997-05-15 |
1998-11-19 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
GB9713980D0
(en)
|
1997-07-03 |
1997-09-10 |
Danbiosyst Uk |
New conjugates
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
US6190913B1
(en)
|
1997-08-12 |
2001-02-20 |
Vijay Singh |
Method for culturing cells using wave-induced agitation
|
|
US7001996B1
(en)
|
1997-08-21 |
2006-02-21 |
The United States Of America As Represented By The Secretary Of The Army |
Enzymatic template polymerization
|
|
US6451527B1
(en)
|
1997-08-29 |
2002-09-17 |
Selective Genetics, Inc. |
Methods using genetic package display for selecting internalizing ligands for gene delivery
|
|
US20040136961A1
(en)
|
1997-10-09 |
2004-07-15 |
Ales Prokop |
Nanoparticulate composition for efficient gene transfer
|
|
DE19745950A1
(de)
|
1997-10-17 |
1999-04-22 |
Dds Drug Delivery Service Ges |
Arzneistoffträgerpartikel für die gewebespezifische Arzneistoffapplikation
|
|
AU734476B2
(en)
|
1997-11-05 |
2001-06-14 |
Baylor College Of Medicine |
Sequences for targeting metastatic cells
|
|
US6254890B1
(en)
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
|
US6242246B1
(en)
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
SE9801923D0
(sv)
|
1998-05-29 |
1998-05-29 |
Independent Pharmaceutical Ab |
Nicotine vaccine
|
|
DE19827164A1
(de)
|
1998-06-18 |
1999-12-23 |
Merck Patent Gmbh |
Katalytisch Titan(IV)-oxid vermittelte geminale symmetrische Dialkylierung von Carbonsäureamiden
|
|
US6429200B1
(en)
|
1998-07-17 |
2002-08-06 |
Mirus Corporation |
Reverse micelles for delivery of nucleic acids
|
|
DE69922206T2
(de)
|
1998-07-22 |
2005-11-24 |
Metabolix, Inc., Cambridge |
Nahrungs- und therapeutische verwendung von hydroxyalkanoat oligomere
|
|
DE19839214C1
(de)
|
1998-08-28 |
2000-05-25 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Herstellung von sphärischen Mikropartikeln mit glatter Oberfläche, die ganz oder teilweise aus mindestens einem wasserunlöslichen linearen Polysaccharid bestehen, sowie mit diesem Verfahren erhältliche Mikropartikel und deren Verwendung
|
|
IL141868A0
(en)
|
1998-10-05 |
2002-03-10 |
M & E Biotech As |
Novel methods for therapeutic vaccination
|
|
EP1117444A2
(en)
|
1998-10-09 |
2001-07-25 |
The University Of Michigan |
Hydrogels and water soluble polymeric carriers for drug delivery
|
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6232082B1
(en)
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
US6403779B1
(en)
|
1999-01-08 |
2002-06-11 |
Isis Pharmaceuticals, Inc. |
Regioselective synthesis of 2′-O-modified nucleosides
|
|
TR200101943T2
(tr)
|
1999-01-08 |
2002-04-22 |
3M Innovative Properties Company |
Bir immun cevap modifayeri ile mukoza ile ilgili durumların tedavisine yönelik formülasyonlar ve metodlar.
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
US20030054360A1
(en)
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
EP1157270A1
(en)
|
1999-02-03 |
2001-11-28 |
Aclara BioSciences, Inc. |
Multichannel control in microfluidics
|
|
US6558951B1
(en)
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
|
US6110462A
(en)
|
1999-03-03 |
2000-08-29 |
The Scripps Research Institute |
Enzymatic DNA molecules that contain modified nucleotides
|
|
GB9905136D0
(en)
|
1999-03-06 |
1999-04-28 |
Danbiosyst Uk |
Surface modification of lamellar particles
|
|
US6943235B1
(en)
|
1999-04-12 |
2005-09-13 |
Agensys, Inc. |
Transmembrane protein expressed in prostate cancer
|
|
US20020102613A1
(en)
|
1999-05-18 |
2002-08-01 |
Hoogenboom Hendricus Renerus Jacobus Mattheus |
Novel Fab fragment libraries and methods for their use
|
|
WO2000077178A1
(en)
|
1999-06-16 |
2000-12-21 |
Boston Biomedical Research Institute |
IMMUNOLOGICAL CONTROL OF β-AMYLOID LEVELS IN VIVO
|
|
US6506887B1
(en)
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
|
WO2001012811A1
(en)
|
1999-08-12 |
2001-02-22 |
Urogenesys, Inc. |
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
|
|
US20020009466A1
(en)
|
1999-08-31 |
2002-01-24 |
David J. Brayden |
Oral vaccine compositions
|
|
US7429639B2
(en)
*
|
1999-09-29 |
2008-09-30 |
Ludwig Institute For Cancer Research |
SSX-2 peptides presented by HLA class II molecules
|
|
US6790631B1
(en)
|
1999-10-05 |
2004-09-14 |
Agensys, Inc. |
G protein-coupled receptor up-regulated in prostate cancer and uses thereof
|
|
US7030228B1
(en)
*
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
WO2001047501A1
(en)
|
1999-12-29 |
2001-07-05 |
Nanodelivery, Inc. |
Drug delivery system exhibiting permeability control
|
|
AU774593C
(en)
|
2000-01-13 |
2005-06-23 |
Nanosphere, Inc. |
Nanoparticles having oligonucleotides attached thereto and uses therefor
|
|
US8202979B2
(en)
|
2002-02-20 |
2012-06-19 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
|
|
US20050020525A1
(en)
|
2002-02-20 |
2005-01-27 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
|
|
US20050032733A1
(en)
|
2001-05-18 |
2005-02-10 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)
|
|
US7534417B2
(en)
|
2000-02-24 |
2009-05-19 |
Agensys, Inc. |
103P2D6: tissue specific protein highly expressed in various cancers
|
|
SE0000933D0
(sv)
|
2000-03-21 |
2000-03-21 |
Independent Pharmaceutica Ab |
Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds
|
|
PT1309726E
(pt)
|
2000-03-30 |
2010-03-08 |
Whitehead Biomedical Inst |
Mediadores de interferência por rna específicos de sequência de rna
|
|
US6610713B2
(en)
|
2000-05-23 |
2003-08-26 |
North Shore - Long Island Jewish Research Institute |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
|
US20020151004A1
(en)
|
2000-07-24 |
2002-10-17 |
Roger Craig |
Delivery vehicles and methods for using the same
|
|
US7253210B2
(en)
|
2002-10-15 |
2007-08-07 |
University Of Tennessee Research Foundation |
Methylene-bridged selective androgen receptor modulators and methods of use thereof
|
|
US20030232792A1
(en)
|
2000-08-24 |
2003-12-18 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
US6838484B2
(en)
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
|
US6998500B2
(en)
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
US20020173495A1
(en)
|
2000-08-24 |
2002-11-21 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
US20040260108A1
(en)
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
|
US7026500B2
(en)
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
|
IL154425A0
(en)
|
2000-08-24 |
2003-09-17 |
Univ Tennessee Res H Corp |
Selective androgen receptor modulators and methods of use thereof
|
|
EP1401801B1
(en)
|
2000-08-24 |
2006-11-02 |
The University Of Tennessee Research Corporation |
Selective androgen receptor modulators and methods of use thereof
|
|
US6503538B1
(en)
|
2000-08-30 |
2003-01-07 |
Cornell Research Foundation, Inc. |
Elastomeric functional biodegradable copolyester amides and copolyester urethanes
|
|
US6376190B1
(en)
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
|
US20040067196A1
(en)
|
2000-10-11 |
2004-04-08 |
Brunke Karen J. |
Targeted therapeutic lipid constructs
|
|
US6589562B1
(en)
|
2000-10-25 |
2003-07-08 |
Salvona L.L.C. |
Multicomponent biodegradable bioadhesive controlled release system for oral care products
|
|
US20040259247A1
(en)
|
2000-12-01 |
2004-12-23 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
TWI246524B
(en)
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
|
US7097837B2
(en)
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US7326564B2
(en)
|
2001-02-20 |
2008-02-05 |
St. Jude Medical, Inc. |
Flow system for medical device evaluation and production
|
|
ATE286430T1
(de)
|
2001-03-22 |
2005-01-15 |
Cognis Iberia Sl |
Nanokapseln
|
|
WO2002076469A1
(en)
|
2001-03-27 |
2002-10-03 |
Baylor College Of Medicine |
A novel technology of intracellular delivery of dna oligonucleotides to improve drug activity
|
|
EP1258528A1
(en)
*
|
2001-05-14 |
2002-11-20 |
GENOPIA Biomedical GmbH |
Expression of membrane proteins using an adenylyl cyclase of Mycobacterium tuberculosis
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
WO2004030608A2
(en)
|
2001-06-05 |
2004-04-15 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
DE60140863D1
(de)
|
2001-06-10 |
2010-02-04 |
Noxxon Pharma Ag |
Verwendung von L-Polynukleotiden zur diagnostischen Bilderzeugung
|
|
US20030022868A1
(en)
|
2001-06-25 |
2003-01-30 |
Dalton James T. |
Selective androgen receptor modulators and methods of use thereof
|
|
AU2775402A
(en)
|
2001-06-29 |
2003-01-02 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
|
JP4088251B2
(ja)
|
2001-07-02 |
2008-05-21 |
オリエンタル酵母工業株式会社 |
ニコチンアミドアデニンジヌクレオチドリン酸（ｎａｄｐ）の製造方法
|
|
BR0103887C1
(pt)
|
2001-07-17 |
2005-11-08 |
Univ Minas Gerais |
Composições imunogênicas contendo microesferas biodegradáveis encapsulando antìgenos, vetores gênicos e adjuvantes
|
|
EP1279404A1
(en)
|
2001-07-26 |
2003-01-29 |
Istituto Superiore di Sanità |
Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases
|
|
JP4607452B2
(ja)
|
2001-08-07 |
2011-01-05 |
ダイナバックス テクノロジーズ コーポレイション |
免疫調節性組成物、製剤およびその使用方法
|
|
US7579163B2
(en)
|
2001-08-16 |
2009-08-25 |
Statoil Asa |
Method of fermentation
|
|
US20060004042A1
(en)
|
2001-08-23 |
2006-01-05 |
Dalton James T |
Formulations comprising selective androgen receptor modulators
|
|
US6818732B2
(en)
|
2001-08-30 |
2004-11-16 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
WO2003028657A2
(en)
|
2001-10-03 |
2003-04-10 |
The Johns Hopkins University |
Compositions for oral gene therapy and methods of using same
|
|
US20030134810A1
(en)
|
2001-10-09 |
2003-07-17 |
Chris Springate |
Methods and compositions comprising biocompatible materials useful for the administration of therapeutic agents
|
|
US6881746B2
(en)
|
2001-12-03 |
2005-04-19 |
Novo Nordick A/S |
Glucagon antagonists/inverse agonists
|
|
AU2002363998A1
(en)
|
2001-12-15 |
2003-06-30 |
Spherics, Inc. |
Bioadhesive drug delivery system with enhanced gastric retention
|
|
US20030235619A1
(en)
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
|
WO2003057670A2
(en)
|
2001-12-28 |
2003-07-17 |
Guilford Pharmaceuticals Inc. |
Indoles as naaladase inhibitors
|
|
US6720008B2
(en)
|
2002-01-22 |
2004-04-13 |
Pr Pharmaceuticals, Inc. |
Composition and method for the encapsulation of water-soluble molecules into nanoparticles
|
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
|
EP1476492A1
(en)
|
2002-02-22 |
2004-11-17 |
Insert Therapeutics Inc. |
Carbohydrate-modified polymers, compositions and uses related thereto
|
|
US20030232013A1
(en)
|
2002-02-22 |
2003-12-18 |
Gary Sieckman |
Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
|
|
US7803970B2
(en)
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
|
US7344700B2
(en)
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
|
CA2476657A1
(en)
|
2002-02-28 |
2003-09-12 |
The University Of Tennessee Research Corporation |
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
EP1487458B1
(en)
|
2002-02-28 |
2011-11-16 |
University Of Tennessee Research Foundation |
Multi-substituted selective androgen receptor modulators and methods of use thereof
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
US7285289B2
(en)
|
2002-04-12 |
2007-10-23 |
Nagy Jon O |
Nanoparticle vaccines
|
|
US7524630B2
(en)
|
2002-04-22 |
2009-04-28 |
University Of Florida Research Foundation, Inc. |
Functionalized nanoparticles and methods of use
|
|
US6819165B2
(en)
|
2002-05-30 |
2004-11-16 |
Analog Devices, Inc. |
Voltage regulator with dynamically boosted bias current
|
|
MXPA04012567A
(es)
|
2002-06-11 |
2005-04-19 |
Ethypharm Sa |
Nanocapsulas lipidicas encubiertas, metodos para la preparacion de las mismas y uso de las mismas como un portador para principios activos.
|
|
GEP20074191B
(en)
|
2002-06-17 |
2007-09-10 |
Univ Tennessee Res Foundation |
N-bridged selective androgen receptor modulators and methods of use thereof
|
|
US7741371B2
(en)
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
|
JP2005533794A
(ja)
|
2002-06-18 |
2005-11-10 |
アーケミックス コーポレイション |
アプタマー−毒素分子およびこれを使用する方法
|
|
AU2003276131A1
(en)
|
2002-06-18 |
2003-12-31 |
Epigenesis Pharmaceuticals, Inc. |
A dry powder oligonucleotide formulation, preparation and its uses
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
NZ538812A
(en)
|
2002-08-15 |
2009-02-28 |
3M Innovative Properties Co |
Immunostimulatory compositions and methods of stimulating an immune response
|
|
US6875605B1
(en)
|
2002-08-21 |
2005-04-05 |
Florida State University Research Foundation, Inc. |
Modular cell culture bioreactor and associated methods
|
|
US7488792B2
(en)
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
|
AU2003267583A1
(en)
|
2002-09-19 |
2004-04-08 |
The Chancellor, Master And Scholars Of The University Of Oxford |
Molecular arrays and single molecule detection
|
|
US7008411B1
(en)
|
2002-09-30 |
2006-03-07 |
Advanced Cardiovascular Systems, Inc. |
Method and apparatus for treating vulnerable plaque
|
|
US20040087810A1
(en)
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
|
AU2003300184B8
(en)
|
2002-12-30 |
2009-12-03 |
3M Innovative Properties Company |
Immunostimulatory combinations
|
|
EP2457892A1
(en)
|
2003-01-13 |
2012-05-30 |
University of Tennessee Research Foundation |
Large-scale synthesis of selective androgen receptor modulators
|
|
US20040156846A1
(en)
|
2003-02-06 |
2004-08-12 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles using L6 antibodies
|
|
JP2006517974A
(ja)
|
2003-02-13 |
2006-08-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
Ｉｒｍ化合物およびトル様受容体８に関する方法および組成物
|
|
WO2004071493A1
(en)
|
2003-02-17 |
2004-08-26 |
Peter Burkhard |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
US20040167103A1
(en)
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20050008572A1
(en)
|
2003-04-29 |
2005-01-13 |
Ales Prokop |
Nanoparticular tumor targeting and therapy
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
US20040266688A1
(en)
|
2003-05-14 |
2004-12-30 |
Nayak Nihar R |
Methods for modulating endometrium
|
|
GB0312309D0
(en)
|
2003-05-29 |
2003-07-02 |
Gaslini Children S Hospital G |
Targeted liposome
|
|
US20060239907A1
(en)
|
2003-06-03 |
2006-10-26 |
The Trustees Of The University Of Pennsylvania |
Stealthy nano agents
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
US7149574B2
(en)
|
2003-06-09 |
2006-12-12 |
Palo Alto Investors |
Treatment of conditions through electrical modulation of the autonomic nervous system
|
|
DE602004028468D1
(de)
|
2003-06-17 |
2010-09-16 |
Mannkind Corp |
Haltung von immunantworten gegen mhc-klasse-i-beschränkte epitope, für prophylaktische oder therapeutische zwecke
|
|
AU2004260935A1
(en)
|
2003-06-30 |
2005-02-10 |
Canji, Inc. |
Polymer encapsulation of adenoviruses
|
|
ES2559828T3
(es)
|
2003-07-16 |
2016-02-16 |
Protiva Biotherapeutics Inc. |
ARN de interferencia encapsulado en lípidos
|
|
US7362068B2
(en)
|
2003-07-23 |
2008-04-22 |
Asmo Co., Ltd. |
Closing member control system
|
|
JP4533382B2
(ja)
|
2003-08-28 |
2010-09-01 |
セルラ・インコーポレイテッド |
マイクロ流体分析およびソーティング用の一体化された構造物
|
|
CN1875101A
(zh)
|
2003-09-02 |
2006-12-06 |
北卡罗来纳-查佩尔山大学 |
生物可降解聚合物－配体偶联物及其在细胞亚群的分离和细胞的低温保藏、培养和移植中的应用
|
|
AU2004281634B2
(en)
|
2003-09-03 |
2011-01-27 |
Dendritherapeutics, Inc. |
Multiplex vaccines
|
|
ES2629696T3
(es)
|
2003-09-17 |
2017-08-14 |
Nektar Therapeutics |
Profármacos poliméricos multibrazo
|
|
US7829119B2
(en)
|
2003-10-20 |
2010-11-09 |
William Marsh Rice University |
Method to fabricate microcapsules from polymers and charged nanoparticles
|
|
US8129506B2
(en)
|
2003-10-24 |
2012-03-06 |
Genzyme Corporation |
Modulation of the interaction of MUC1 with MUC1 ligands
|
|
TW200527013A
(en)
|
2003-10-28 |
2005-08-16 |
Arryx Inc |
System and method for manipulating and processing materials using holographic optical trapping
|
|
WO2005055949A2
(en)
|
2003-12-09 |
2005-06-23 |
The Children's Hospital Of Philadelphia |
Sustained release preparations composed of biocompatible complex microparticles
|
|
DK1704585T3
(en)
|
2003-12-19 |
2017-05-22 |
Univ North Carolina Chapel Hill |
Methods for preparing isolated micro- and nanostructures using soft lithography or printing lithography
|
|
US7335744B2
(en)
|
2003-12-23 |
2008-02-26 |
The Regents Of The California University |
Prostate cancer specific internalizing human antibodies
|
|
WO2005065418A2
(en)
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
EP1713514B1
(en)
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
WO2005084639A2
(en)
|
2004-03-03 |
2005-09-15 |
Spherics, Inc. |
Polymeric drug delivery system for hydrophobic drugs
|
|
WO2005110438A2
(en)
|
2004-04-15 |
2005-11-24 |
Massachusetts Institute Of Technology |
Methods and products related to the intracellular delivery of polysaccharides
|
|
AU2005325262B2
(en)
|
2004-04-27 |
2011-08-11 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety
|
|
ES2246695B1
(es)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
|
|
WO2005112885A2
(en)
|
2004-05-12 |
2005-12-01 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
|
CN100475837C
(zh)
|
2004-06-11 |
2009-04-08 |
北京键凯科技有限公司 |
多叉分支的聚乙二醇-氨基酸寡肽及其活性衍生物和药物结合物
|
|
WO2005122885A2
(en)
|
2004-06-14 |
2005-12-29 |
Cephos Corp. |
Systems and methods for detecting deception by measuring brain activity
|
|
JP2008512350A
(ja)
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
|
US20060258628A1
(en)
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
|
CN101027100A
(zh)
|
2004-07-22 |
2007-08-29 |
健泰科生物技术公司 |
治疗干燥综合征的方法
|
|
EP1791943A1
(en)
|
2004-09-22 |
2007-06-06 |
CatchMabs B.V. |
Bioreactor assembly comprising at least one tray-like rocking platform
|
|
US9079765B2
(en)
|
2004-10-01 |
2015-07-14 |
Midatech Ltd. |
Nanoparticles comprising antigens and adjuvants, and immunogenic structures
|
|
AU2005294214A1
(en)
|
2004-10-07 |
2006-04-20 |
Emory University |
Multifunctional nanoparticles conjugates and their use
|
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
DK1817340T3
(da)
|
2004-11-12 |
2012-08-13 |
Xencor Inc |
Fc-varianter med ændret binding til fcrn
|
|
US20060111271A1
(en)
|
2004-11-24 |
2006-05-25 |
Cerny Erich H |
Active and passive immunization against pharmacologically active hapten molecules using a synthetic carrier compound composed of similar elements
|
|
WO2006066158A2
(en)
|
2004-12-14 |
2006-06-22 |
Alnylam Pharmaceuticals, Inc. |
Rnai modulation of mll-af4 and uses thereof
|
|
WO2006090924A1
(ja)
|
2005-02-28 |
2006-08-31 |
The University Of Tokyo |
ペプチドリガンドを有するブロック共重合体
|
|
WO2006096754A2
(en)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to psma and their use as prostate cancer therapeutics
|
|
EP1872793B1
(en)
*
|
2005-04-20 |
2012-10-10 |
Mitsuru Akashi |
Polyamino acid for use as adjuvant
|
|
EP1877069A2
(de)
|
2005-05-04 |
2008-01-16 |
Noxxon Pharma AG |
Neue verwendung von spiegelmeren
|
|
CA2606861C
(en)
*
|
2005-05-05 |
2012-08-07 |
Sanofi-Aventis U.S. Llc |
Stable nanoparticle formulations
|
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
|
WO2006133271A2
(en)
|
2005-06-06 |
2006-12-14 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
EP1898955A2
(en)
|
2005-06-17 |
2008-03-19 |
Nektar Therapeutics AL, Corporation |
Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs
|
|
CA2619533C
(en)
|
2005-08-17 |
2014-02-04 |
Bioneer Corporation |
Sirna-hydrophilic polymer conjugates for intracellular delivery of sirna and method thereof
|
|
EP1932538A4
(en)
|
2005-08-25 |
2009-10-21 |
Taiho Pharmaceutical Co Ltd |
BIODEGRADABLE NANOTEHICLES WITH IMMOBILIZED OR CAPACITATED T-CELL-RECOGNIZABLE EPITOPEPEPID
|
|
NZ568211A
(en)
*
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
EP1973608A1
(en)
|
2005-12-14 |
2008-10-01 |
Cytos Biotechnology AG |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
KR101529318B1
(ko)
|
2005-12-19 |
2015-06-16 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
US20070231392A1
(en)
|
2006-01-23 |
2007-10-04 |
Ernst Wagner |
CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
WO2007109364A2
(en)
|
2006-03-20 |
2007-09-27 |
The General Hospital Corporation |
Intramolecularly quenched fluorochrome conjugates and methods of use
|
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
|
CA2648243C
(en)
|
2006-04-11 |
2015-12-22 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
|
US20100247653A1
(en)
|
2006-04-11 |
2010-09-30 |
Hans Lautenschlager |
Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
|
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US20110052697A1
(en)
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
CN101467235A
(zh)
|
2006-06-13 |
2009-06-24 |
Nxp股份有限公司 |
双栅极晶体管及其制造方法
|
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20090117549A1
(en)
|
2006-07-18 |
2009-05-07 |
Weihong Tan |
Aptamer-based methods for identifying cellular biomarkers
|
|
JP4936312B2
(ja)
*
|
2006-07-20 |
2012-05-23 |
株式会社島津製作所 |
新規な両親媒性物質、それを用いた薬剤搬送システム及び分子イメージングシステム
|
|
US20100144845A1
(en)
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
US20080171059A1
(en)
|
2006-08-07 |
2008-07-17 |
Shanshan Wu Howland |
Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens
|
|
WO2008041703A1
(en)
*
|
2006-10-02 |
2008-04-10 |
Osaka University |
Adjuvant for influenza vaccine and influenza vaccine
|
|
WO2008147456A2
(en)
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
EP2099496A2
(en)
|
2006-12-08 |
2009-09-16 |
Massachusetts Institute of Technology |
Delivery of nanoparticles and/or agents to cells
|
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
|
US20080311045A1
(en)
|
2007-06-06 |
2008-12-18 |
Biovaluation & Analysis, Inc. |
Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
|
|
EP2630966B1
(en)
|
2007-10-12 |
2017-04-19 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
|
RU2540871C2
(ru)
|
2008-02-01 |
2015-02-10 |
Альфа-О Пептидес Аг |
Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|